Literature DB >> 23881239

Safety and tolerability of tenofovir for preexposure prophylaxis among men who have sex with men.

Sten H Vermund.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23881239      PMCID: PMC3819194          DOI: 10.1097/QAI.0b013e3182a3979c

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  52 in total

1.  HIV prevention in women: next steps.

Authors:  Sten H Vermund; Lut Van Damme
Journal:  Science       Date:  2011-01-21       Impact factor: 47.728

Review 2.  Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV.

Authors:  James D Campbell; Jeffrey H Herbst; Robert T Koppenhaver; Dawn K Smith
Journal:  Am J Prev Med       Date:  2013-01       Impact factor: 5.043

3.  Modelling the impact of HIV prevention and treatment for men who have sex with men on HIV epidemic trajectories in low- and middle-income countries.

Authors:  A L Wirtz; D G Walker; L Bollinger; F Sifakis; S Baral; B Johns; R Oelrichs; C Beyrer
Journal:  Int J STD AIDS       Date:  2013-05-06       Impact factor: 1.359

4.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

Review 5.  Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence.

Authors:  Connie Celum; Jared M Baeten
Journal:  Curr Opin Infect Dis       Date:  2012-02       Impact factor: 4.915

Review 6.  Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.

Authors:  Andrew M Hall; Bruce M Hendry; Dorothea Nitsch; John O Connolly
Journal:  Am J Kidney Dis       Date:  2011-03-23       Impact factor: 8.860

Review 7.  Engaging healthcare providers to implement HIV pre-exposure prophylaxis.

Authors:  Douglas Krakower; Kenneth H Mayer
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

8.  Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand.

Authors:  Arunrat Tangmunkongvorakul; Suwat Chariyalertsak; K Rivet Amico; Pongpun Saokhieo; Vorawan Wannalak; Thirayut Sangangamsakun; Pedro Goicochea; Robert Grant
Journal:  AIDS Care       Date:  2012-12-19

9.  Risk factors for HIV and unprotected anal intercourse among men who have sex with men (MSM) in Almaty, Kazakhstan.

Authors:  Mark Berry; Andrea L Wirtz; Assel Janayeva; Valentina Ragoza; Assel Terlikbayeva; Bauyrzhan Amirov; Stefan Baral; Chris Beyrer
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

10.  Changing epidemiology of HIV in Mumbai: an application of the Asian epidemic model.

Authors:  Ram Manohar Mishra; Madhulika Dube; Damodar Sahu; Niranjan Saggurti; Arvind Pandey
Journal:  Glob J Health Sci       Date:  2012-08-05
View more
  1 in total

Review 1.  Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data.

Authors:  Ashley O Otto; Christina G Rivera; John D Zeuli; Zelalem Temesgen
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.